VetPharm in Feed & Additive Magazine II.

Interview with our Key Account Manager, Barbara Brutsaert - 2nd part

In the second part of our interview with Feed & Additive Magazin, we explore VetPharm’s application-driven R&D philosophy, which prioritizes measurable field results over isolated theoretical benefits.

Join us as we examine how collaboration with veterinarians is shaping the next generation of solutionsfrom the stability of orthosilicic acid to the international rollout of Poulsil in markets like Brazil and Asia.

emphasis is placed on diagnostics and data analysis. For example, tools such as Reovirus diagnostics and vaccination program evaluations are used to identify underlying issues and guide decision making for choosing the right additives to counter losses in the short term. This allows VetPharm to move beyond generic recommendations and provide targeted, customer-tailored solutions.”

Q: “In your opinion, what are the biggest challenges that producers face today in the field of animal nutrition and health? What kind of solutions does VetPharm offer to address these challenges?”

Barbara: “Poultry producers are currently operating in an environment of increasing complexity. One of the key challenges is the need for rapid coordination between producers, veterinarians, and nutritionists to ensure timely and effective responses to health and performance issues.

At the same time, production demands continue to rise. Laying hens are expected to maintain high performance levels over extended cycles, often up to 100 weeks. This places significant pressure on skeletal health, metabolism, and overall resilience. Raw material availability and variability also represent a constraint, requiring more precise and efficient nutritional strategies. 

In this context, certain nutrients that have historically received less attention are becoming increasingly relevant. Bioavailable silicium is one such example. It plays an important role in collagen synthesis and structural integrity but is overlooked in standard formulations. Poulsil addresses this by delivering silicium in the form of orthosilicic acid (OSA), which is highly bioavailable after ingestion. Its mesoporous structure allows for stability and controlled release across the gastrointestinal tract, ensuring consistent absorption under varying pH conditions. This contributes to improved bone strength, eggshell quality, and overall robustness, supporting both performance and animal welfare in demanding production systems.”

Q: “Looking back at the conference, which scientific or industry trends stood out the most? How will these trends shape VetPharm’s future strategy?”

Barbara: “VetPharm is an internationally active company specializing in the distribution of veterinary pharmaceuticals, vaccines, and feed additives. The company focuses on delivering scientifically validated solutions that support animal health, welfare, and production efficiency under commercial conditions. Rather than operating as a traditional distributor, VetPharm positions itself as a technical partner to veterinarians, nutritionists, and producers.

This involves combining product supply with high-end technical field expertise, offering total solutions and ensuring these are correctly implemented and deliver measurable results. The company’s activities are particularly strong in the poultry sector, where it integrates nutritional support, veterinary solutions, and diagnostic services. This combined approach allows VetPharm to address complex health and performance challenges in a structured and practical way.”

ICPIH_Event_GroupPhoto_of_VetPharm_Professionals
Q: “Where does VetPharm position itself within this global transition?”

Barbara: “VetPharm’s positioning is closely aligned with these developments. The company focuses on strengthening animal robustness and efficiency as a way to support high-end production systems.

Nutritional strategies play a key role in this approach. By improving structural integrity and resilience, it is possible to reduce the need for therapeutic interventions and support better performance. Poulsil contributes to this by enhancing collagen formation, which improves bone strength and mobility. This is particularly relevant in long production cycles or fast-growing animals, where skeletal issues have become a limiting factor for the genetics we have today across the breeder, broiler and layer sectors.

 In laying hens, this supports sustained production and helps reduce osteoporosis-related issues. In breeders, improved structural health is associated with better reproductive performance and hatchability. At this conference, we demonstrated that silicium supplementation has a clear effect on reducing the losses following a Reovirus infection by improving tendon health, contributing to improved gait and overall flock condition. The results were validated not only in end weight of the broilers but also with an improved condition of the tendons as shown by the blinded histology results.”

Q: “Finally, what will VetPharm’s growth targets and priority focus areas be in the coming period?”

Barbara: “While the company has established a solid presence in Western Europe, there is significant potential in other regions with expanding poultry sectors. The international rollout of Poulsil is a key priority, alongside selected vaccines and nutritional products. Markets such as Brazil and Asia are of particular interest due to their scale and strategic importance in global poultry production. In addition to geographic expansion, VetPharm will continue to invest in technical support, partnerships, and product development. The aim is to strengthen its position as a solution-oriented partner capable of addressing both current and emerging industry challenges.”

We would like to extend our sincere thanks to Feed & Additive Magazine for providing this platform to discuss the evolving landscape of poultry health and the science-driven philosophy behind our work. It was a privilege to share VetPharm’s journey and our commitment to bridging the gap between laboratory research and practical field application.

Missed Part I?

If you missed the first part of our conversation, where we discuss VetPharm’s founding story, our core solutions, and our strategic approach to the international poultry sector, you can catch up by clicking the button below.

VetPharm in Feed & Additive Magazine I.

Interview with our Key Account Manager, Barbara Brutsaert - 1st part

Barbara Brutsaert, Key Account Manager at VetPharm:

 “VetPharm’s main strength lies in its integration of scientific knowledge with field application. The company works closely with veterinarians and producers to ensure that its recommendations are grounded in real production conditions. A strong emphasis is placed on diagnostics and data analysis. For example, tools such as Reovirus diagnostics and vaccination program evaluations are used to identify underlying issues and guide decision making for choosing the right additives to counter losses in the short term. This allows VetPharm to move beyond generic recommendations and provide targeted, customer-tailored solutions.”

In this exclusive interview with Feed & Additive Magazine, Brutsaert walks us through the company’s science-driven yet field-first philosophy, and the growing relevance of overlooked nutrients like orthosilicic acid in today’s demanding production systems. From the pressure on laying hens in extended cycles to the latest findings on silicium supplementation and Reovirus-related tendon health, the conversation offers a candid look at where poultry nutrition is heading and how VetPharm intends to be part of that future.

Q: “It was a pleasure connecting with you during the 9th International Conference on Poultry Intestinal Health. What role do international platforms like ICPIH play in advancing the poultry industry?”

Barbara: “International platforms such as the International Conference on Poultry Intestinal Health (ICPIH) play an important role in advancing both scientific understanding and practical application. They provide a forum where researchers and industry professionals can exchange knowledge and align on emerging challenges. This is particularly relevant in the field of intestinal health, which is influenced by multiple interacting factors, including nutrition, microbiota, immunity, and management practices. Such events also facilitate the translation of research into field application. In a rapidly evolving industry, this connection between science and practice is essential for developing effective and scalable solutions. Fostering collaboration and networking among industry professionals is becoming more and more important in a consolidating industry.”

Q: “For our readers who may not be familiar with VetPharm yet, how would you describe your company? What are the core solutions you provide to the animal nutrition and health industry?”

Barbara: “VetPharm is an internationally active company specializing in the distribution of veterinary pharmaceuticals, vaccines, and feed additives. The company focuses on delivering scientifically validated solutions that support animal health, welfare, and production efficiency under commercial conditions. Rather than operating as a traditional distributor, VetPharm positions itself as a technical partner to veterinarians, nutritionists, and producers. This involves combining product supply with high-end technical field expertise, offering total solutions and ensuring these are correctly implemented and deliver measurable results. The company’s activities are particularly strong in the poultry sector, where it integrates nutritional support, veterinary solutions, and diagnostic services. This combined approach allows VetPharm to address complex health and performance challenges in a structured and practical way.”

Q: “What is the founding story of VetPharm? What need gave birth to the company, and how has this vision evolved to where it stands today?”

Barbara: “VetPharm was founded in 2011 to address a gap between product manufacturers and end users in the livestock sector. At the time, there was a clear need for a partner capable of combining access to products for gut health and Mycoplasma control with world-class technical knowledge and field-level support. A product can be the best in class, but not understanding how to use it can completely undermine its activity and return on investment. The company initially focused on key poultry health challenges, particularly intestinal health and respiratory diseases. Although these are still a cornerstone of the company, its role has evolved significantly. Today, VetPharm operates as a solution-oriented partner, combining products with diagnostics, advisory services, and field validation. A notable development in this evolution has been the introduction of Poulsil, a bioavailable silicium-based feed additive. It reflects the company’s focus on targeted innovations that address specific physiological bottlenecks in modern poultry production.”

Q: “What are the key strengths that differentiate VetPharm in the sector? Particularly in terms of scientific approach and field applications, what is your positioning?”

Barbara: “VetPharm’s main strength lies in its integration of scientific knowledge with field application. The company works closely with veterinarians and producers to ensure that its recommendations are grounded in real production conditions. A strong emphasis is placed on diagnostics and data analysis. For example, tools such as Reovirus diagnostics and vaccination program evaluations are used to identify underlying issues and guide decision-making for choosing the right additives to counter losses in the short term. This allows VetPharm to move beyond generic recommendations and provide targeted, customer-tailored solutions. Combined with a focus on product quality and technical support, this approach positions the company as a practical and reliable partner in the field.”

As we move beyond the founding vision of the company, our discussion turns toward the specific innovations solving real-world production bottlenecks. In the second part of our interview, we explore VetPharm’s application-driven R&D philosophy, which prioritizes measurable field results over isolated theoretical benefits. Join us as we examine how collaboration with veterinarians is shaping the next generation of solutions—from the stability of orthosilicic acid to the international rollout of Poulsil in markets like Brazil and Asia.

Boost Poultry Performance & Egg Quality with Bioactive Silicium

In today’s competitive poultry industry, every advantage counts. Whether you’re raising breeders, layers, or broilers, optimizing bone strength, eggshell integrity and overall flock welfare are critical for productivity and profitability.

That’s where Poulsil® comes in — a scientifically-formulated, bioactivated silicium (Si) additive developed for poultry feed to deliver measurable results.

What is Poulsil®?

Poulsil® is a patented mesoporous-silica based formulation that ensures high bioavailability of silicium.

Key points:

  • Delivers bioactive silicium that supports collagen synthesis, bone mineralisation and connective tissue integrity.
  • Designed for poultry (breeders, layers and broilers) to enhance both welfare and production performance.
  • Compatible with existing feeding programs: easy to integrate into feed regimes.
How It Works – The Science Behind It
  • Collagen synthesis: Silicium plays an essential role in formation of collagen and connective tissue. By providing a bioavailable form, Poulsil® supports better structural architecture in bones and shells.
  • Bone mineralisation: Improved bone density and reduced risk of fractures or leg issues in birds.
  • Eggshell & shell-membrane strength: Enhanced static stiffness and higher rupture force in eggshells result in stronger shells, reduced incidence of cracked or shell-less eggs, and improved hatchability in breeders.
Why Choose Poulsil®?
  • Scientifically validated: backed by trials and research.
  • Easy to integrate: adds to your feed program without major disruption.
  • Measurable welfare gains: stronger bones and shells lead to reduced losses and improved animal welfare.
  • Economic impact: fewer cracked eggs, reduced culling, improved productivity = better margin.
  • Global applicability: suited for breeders, layers and broilers in diverse production settings.
Proven Benefits and Trial Results

Here are some of the compelling outcomes from field trials:

  • In one Belgian broiler-breeder trial (22 – 30 weeks), the Poulsil® group had a cracked egg rate of 1.78% compared with 2.67% in the control.
  • Improved laying percentage in broiler breeders: Control 86.5% vs Poulsil® 87.6% (weeks 30–39).
  • Laying percentage in a commercial layer trial in the Philippines: Control 90.18% vs Poulsil® 90.32% (weeks 52–57).
  • In one broiler-breeder trial in Belgium (22 – 60 weeks), DOC/hen placed was 165.3 in the Poulsil® group compared to 161.0 in the control group. Poulsil® group had fewer cracked eggs, higher laying percentage and better hatchability.
  • Increased eggshell static stiffness: treatment groups showed better shell resilience than controls.
  • Better feed conversion and overall performance – healthier birds, stronger bones.
Application & Recommendations

Suggested use:

  • Include Poulsil® in feed for breeders, layers and broilers at 150 g/ton of feed
  • Ideal to start at key production phases: early growth, peak lay, or shell-quality risk periods.
  • Combine with a well-balanced diet, good management practices and proper housing for maximal effect.

Ready to elevate your poultry performance?

Contact Vetpharm today to request the full Poulsil® brochure, access trial data, and find distributors in your region.

Stronger Shells. Healthier Chicks. Smarter Profits.

Every egg counts—especially when it comes to hatching eggs from your broiler breeders. Cracked or thin-shelled eggs mean fewer eggs per hen house, lower hatchability, and potentially weaker chicks.

That’s why more producers are turning to bioavailable silicium (Poulsil®)—a breakthrough innovation that strengthens eggs from the inside out.

Silicium plays a key role in collagen and eggshell membrane synthesis, helping to organize the mineral matrix where calcium carbonate crystals form.
The result? Thicker, stronger, more uniform shells—and fewer cracks at the hatchery.

In controlled farm and hatchery trials, supplementation with Poulsil® (150 g/ton feed) led to:

  • Up to one-third fewer cracked eggs
  • Improved shell thickness and static stiffness
  • Tangible economic returns by week 60

When egg quality improves, everything downstream does too—better hatchability, stronger chicks, and higher overall ROI.

Ready to future-proof your breeder performance?
Learn more about Poulsil® and its proven benefits at poulsil.com or contact Vetpharm today.

You can also download the poster presented at WVPAC in Kuching, Malaysia by clicking the button here below: